An Insight to Hyponatremia in Cirrhosis: Pathophysiology and Management Approaches
Keywords:
Hyponatremia, Prognostic significance, Diagnosis, Vaptans, Urea, ?-opioid agonists,Abstract
Cirrhosis is considered by systemic and splanchnic vasodilation that principals to extreme nonosmotic excretion of vasopressin. Hyponatremia is a mutual electrolyte irregularity in progressive liver disease that outcomes from the diminished capability of the kidney to excrete solute-free water that principals to “dilutional” hyponatremia water retention uneven to the retaining of sodium. Hyponatremia is mutual in cirrhosis. It frequently happens in a progressive phase of the disease and is related with problems and augmented mortality. Moreover, hypovolemic, or more usually, hypervolemic hyponatremia might be seen in cirrhosis. Diminished renal sodium treatment due to augmented arginine-vasopressin secretion and renal hypoperfusion secondary to condensed functioning volumia due to peripheral arterial vasodilation specify the chief mechanisms principal to dilutional hyponatremia in this setting. The foremost pathogenic influence responsible for hyponatremia is a nonosmotic hypersecretion of arginine vasopressin from the neurohypophysis associated to circulatory dysfunction. The treatment of choice for hypervolemic hyponatremia is fluid restraint. Vaptans, drugs that are selective antagonists of vasopressin V2 receptors, appeared as the first pharmacological treatment of hypervolemic hyponatremia in cirrhosis with auspicious results. Though, satavaptan was inhibited from expansion for safety reasons and tolvaptan is not suggested in patients with liver disease. Consequently, now there is no actual and safe pharmacological method accessible for the management of hypervolemic hyponatremia in cirrhosis. In this review we are going to highlight the pathophysiology and treatment methods.
Keywords: Hyponatremia, prognostic significance, diagnosis, vaptans, urea, κ-opioid agonists
Cite this Article
Asad Jamal Ansari, Mohammad Monawwar, Nishat Fatima, Mohd Imran, Shayna Bano, Mehtab Alam. An Insight to Hyponatremia in Cirrhosis: Pathophysiology and Management Approaches. Research & Reviews: A Journal of Immunology. 2020; 10(3): 30–46p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
